Effects of Neoadjuvant Chemotherapy on Hormone Receptor Expression in Breast Cancer
-
Published:2022
Issue:01
Volume:12
Page:684-693
-
ISSN:2161-8712
-
Container-title:Advances in Clinical Medicine
-
language:
-
Short-container-title:ACM
Publisher
Hans Publishers
Subject
General Engineering
Reference47 articles.
1. Piper, G.L., Patei, N.A., Patei, J.A., et al. (2004) Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer Results in Alterations in Preoperative Tumor Marker Status. The American Surgeon, 70, 1103-1106. 2. Lee, S.H., Chung, M.A., Quddu, M.R., et al. (2003) The Effect of Neoadjuvant Chemotherapy on Estrogen and Progesterone Receptor Expression and Hormone Receptor Status in Breast Cancer. The American Journal of Surgery, 186, 348-350. httpss://doi.org/10.1016/S0002-9610(03)00271-X 3. Taucher, S., Rudas, M., Gnant, M., et al. (2003) Sequential Steroid Hormone Receptor Measurements in Primary Breast Cancer with and without Intervening Primary Chemotherapy. Endocrine-Related Cancer, 10, 91-98. httpss://doi.org/10.1677/erc.0.0100091 4. Makris, A., Powles, T.J., Alred, D.C., et al. (1999) Quantitative Changes in Cytological Molecular Markers during Primary Medical Treatment of Breast Cancer: A Pilot Study. Breast Cancer Research and Treatment, 53, 51-59. httpss://doi.org/10.1023/A:1006179511178 5. Brennan, M.E., Kerin-Ayres, K., Perera, S. and Samarakoon, S. (2020) The Emergence of Breast Care Nursing in A Developing Nation: A Sri Lankan-Australian Training Partnership. Asia-Pacific Journal of Oncology Nursing, 7, 49-54. httpss://doi.org/10.4103/apjon.apjon_40_19
|
|